newsfilter
← Latest News
PR Newswire·

Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing Determination

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that the Nasdaq Hearings Panel has agreed to the transfer of the Company's...